Home › Books › FDA can find no objections in CI audit. (Clinical investiga…
FDA can find no objections in CI audit. (Clinical investigators).(Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio; clinical investigator, ... article from: Bioresearch Monitoring Alert Buy on Amazon

https://www.ebooknetworking.net/books_detail-B0008DOUZK.html

FDA can find no objections in CI audit. (Clinical investigators).(Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio; clinical investigator, ... article from: Bioresearch Monitoring Alert

AuthorTamra Sami
PublisherWashington Information Source
Shop on Amazon — choose your country
🇺🇸 USA 🇨🇦 Canada 🇬🇧 UK 🇩🇪 Germany 🇫🇷 France 🇮🇳 India
5.95 USD
Buy New on Amazon 🇺🇸

Book Details

Author(s)Tamra Sami
PublisherWashington Information Source
ISBN / ASINB0008DOUZK
ISBN-13978B0008DOUZ8
MarketplaceUnited States  🇺🇸

More Books by Tamra Sami

IVD exporter caught with 'cat in the bag,' as FDA warns firm about rodent control, QS deficiencies.(Medical devices): An article from: Validation Times
IVD exporter caught with 'cat in the bag,' a…
View
IRB kept sloppy records, failed to review critical information.(IRBs)(Huntsville Hospital)(Institutional Review Board ): An article from: Bioresearch Monitoring Alert
IRB kept sloppy records, failed to review critical inf…
View
GCP inspections to be nation-based; pharma firms advised to 'get it right first time' for Phase I trials.(EU Clinical trials)(Good Clinical Practices): An article from: Bioresearch Monitoring Alert
GCP inspections to be nation-based; pharma firms advis…
View
Canada aims for 7-day approval for Phase I trials; rules redefine sponsors.(Canada): An article from: Bioresearch Monitoring Alert
Canada aims for 7-day approval for Phase I trials; rul…
View
Subpart C on prisoner research should be scrapped, SACHRP told.(United States. Office for Human Research Protections. Secretary's Advisory Committee ... An article from: Bioresearch Monitoring Alert
Subpart C on prisoner research should be scrapped, SAC…
View
AAI lacked validation data, evades 483.(Human drugs): An article from: Validation Times
AAI lacked validation data, evades 483.(Human drugs): …
View
OTC manufacturer changes product specs following validation.(Human drugs): An article from: Validation Times
OTC manufacturer changes product specs following valid…
View
Study coordinator complaint triggers four-month audit, resulting in 12-page 483. (Clinical investigators).: An article from: Bioresearch Monitoring Alert
Study coordinator complaint triggers four-month audit,…
View
Documentation issues follow Florida investigator from NIH. (Sponsor-monitors/GLP).(National Institutes of Health, University of Florida; assays for drug): An article from: Bioresearch Monitoring Alert
Documentation issues follow Florida investigator from …
View
Batelle receives 483 for inadequate maintenance of facility, procedural issues in GLP inspection. (Sponsor-monitors/GLP).(Batelle Memorial Institute, ... An article from: Bioresearch Monitoring Alert
Batelle receives 483 for inadequate maintenance of fac…
View
Donate to EbookNetworking
Prev
Next